Isotretinoin Therapy for Male Infertility

Male infertility remains a complex clinical challenge, particularly for patients with oligozoospermia and azoospermia, where effective therapeutic options are limited. Emerging research suggests that retinoic acid signaling plays a critical role in regulating spermatogenesis, opening new avenues for potential treatment strategies. This virtual session will explore the biological role of retinoic acid in sperm development, review recent studies examining the impact of isotretinoin therapy on spermatogenesis, and discuss which patient populations may benefit from this emerging approach. Join us for an engaging discussion that bridges basic reproductive biology with evolving clinical applications, offering valuable insights for clinicians and researchers interested in advancing the management of male infertility.

Moderator: Nahid Punjani, MD, MPH, Mayo Clinic, Department of Urology

Speaker: Nahid Punjani, MD, MPH, Mayo Clinic, Department of Urology

Don't miss out on this exciting webinar! Register today

Can't attend live? The recording will be available on ASRM Academy after the event.

Continuous Engagement 

April 6 – May 1, 2026
To extend learning beyond the live session, ASRM Academy offers a dedicated Continuous Engagement period, allowing attendees to continue the conversation after the virtual session concludes. Through this feature, ASRM and SMRU members can submit questions related to the session content, enabling deeper discussion, clarification of key concepts, and continued interaction with the material.